NPPES file of Aug 9, 2026

Alina Rubinshteyn, PHARM D.

Pharmacist · Staten Island, NY

Alina Rubinshteyn, PHARM D. is a pharmacist with a practice address in Staten Island, New York, and NPI 1396078911, issued on Sep 14, 2009. Check the license (New York 052938, as entered in NPPES) with the New York board that licenses this profession; the Medicare figures below come from public CMS files.

Record from CMS NPPES, file of Aug 9, 2026 · Medicare files 2024 · method · Verify with CMS →

NPPES recordNPPES file of Aug 9, 2026
1396078911
Name
Alina Rubinshteyn
Credential
PHARM D.
Primary taxonomy
Pharmacist 183500000X
License number
052938 NY
Self-reported in NPPES; status is on the state search
Practice location
3155 Amboy RD, Staten Island, NY 10306
Phone
(718) 351-7746
Enumerated
Sep 14, 2009
Record last updated
Apr 30, 2015 (not updated in 11 years: call before relying on the address or phone)
Fax
(718) 351-8864
Entity
Type 1 · individual
Public record from CMS NPPES (open it on the CMS NPI Registry). A record is not a license: verify it with the state board.
Download card Updates feed

Also registered at 3155 Amboy RD

A shared address usually means a shared clinic or building; it does not show who employs whom.

  1. Sandra Andrawis, PHARMDPharmacist1053800870
  2. Ikechukwu AnekeLicensed Practical Nurse1033406889
  3. Paul AnsahLicensed Practical Nurse1144544495
  4. Joanne Benimoff, RNRegistered Nurse1245475268
  5. Jo-Ellen BranniganRegistered Nurse1124341367
  6. Deborah BurgRegistered Nurse1184911935

Verify Alina Rubinshteyn in five checks

  1. 1IdentityNPI record in CMS NPPESNPI lookupConfirmed in NPPES
  2. 2LicenseActive license and public ordersWhich New York board licenses this profession
    Search for license 052938
    Check the board
  3. 3Other statesLicenses and actions elsewhereDocInfo (FSMB)Not checked
  4. 4ExclusionsMedicare and Medicaid bansHHS-OIG exclusion listNot checked
  5. 5CertificationBoard certificationABMS AOA NCCPA AANPNot checked
Find the New York license search

PlainDoctor does not match the HHS-OIG exclusion list to individual records: most entries carry no NPI. Search the OIG exclusion list by name.

Is this page about you? You can ask us to correct, restrict or remove it: how.

Most of these Medicare Part D claims are vaccines, 100% of the cost of the top drugs

39 Medicare Part D claims for 33 beneficiaries, against an average of 119 among the 28,524 providers of this specialty who prescribed in Part D. Brand-name drugs were 100% of claims.

  1. Alina Rubinshteyn39
  2. Specialty average119

Most prescribed

Pharmacies often give vaccines under a standing order that names one clinician, and CMS counts every such claim under that clinician's NPI. These claims are therefore not a measure of this clinician's own prescribing.

  1. Shingrix18 claims
  2. Arexvy14 claims

Source: CMS Medicare Part D Prescribers by Provider and Drug, 2024 (data.cms.gov). Part D covers prescriptions for Medicare patients only; drugs with fewer than 11 claims are not published.

Alina Rubinshteyn among 22,962 pharmacist records in New York

Alina Rubinshteyn, PHARM D. is one of 22,962 pharmacist records with a practice address in New York. under 1% of them appear in a Medicare file (Part D prescribing, MIPS, Open Payments or Medicare group billing); this one does. Its NPI, issued in 2009, is newer than 27% of them.

  • NPI issued2009 · 27% of these records are older, 70% newer
  • In a Medicare fileYes · under 1% of these records are
  • In the CMS Doctors and Clinicians fileNo · 0% of these records are
  • Record last updated2015 · 79% of these records were not updated in five years or more

Source: CMS NPPES, file of Aug 9, 2026, every record with primary taxonomy 183500000X and a New York practice address; Medicare files: CMS Part D Prescribers 2024, MIPS 2023, Open Payments 2024, Doctors and Clinicians (data.cms.gov).

528 pharmacist records list a practice address in Staten Island

They are 528 of the 12,351 NPPES records with a practice address in Staten Island, and 22,962 pharmacist records in New York.

The 8 pharmacist records with the nearest ZIP codes

  1. Wajdi Abuzahrieh, RPHStaten Island, NY 103061073797155
  2. John CandelaStaten Island, NY 103061912036849
  3. Kim FanizzaStaten Island, NY 103061447420567
  4. Andrea Fox, BS PHARMStaten Island, NY 103061720257231
  5. William Gitman, RPHStaten Island, NY 103061720172299
  6. Doug HahnStaten Island, NY 103061427227065
  7. Regina LakhterStaten Island, NY 103061598933343
  8. Tatyana Levik, RPHStaten Island, NY 103061861670796

Common questions

What is Alina Rubinshteyn, PHARM D.'s NPI number?

Alina Rubinshteyn, PHARM D.'s National Provider Identifier (NPI) is 1396078911, issued on Sep 14, 2009. An NPI identifies a provider in billing; it is not a license.

Where is Alina Rubinshteyn, PHARM D. located?

The NPPES record lists a practice address at 3155 Amboy RD, Staten Island, NY, 10306. Phone: (718) 351-7746. Providers update this record themselves, so call before visiting.

How can I verify Alina Rubinshteyn, PHARM D.'s license?

NPPES lists New York license number 052938, as entered by the provider. Search the New York board that licenses this profession; the NPPES record confirms identity only.

How much does Alina Rubinshteyn, PHARM D. prescribe under Medicare Part D?

In 2024, Alina Rubinshteyn, PHARM D. had 39 Medicare Part D claims for 33 beneficiaries; the average among pharmacist prescribers was 119. Part D covers Medicare prescriptions only.

Source: CMS National Plan and Provider Enumeration System (NPPES), file of Aug 9, 2026 (NPPES files on CMS.gov); NUCC Health Care Provider Taxonomy. Medicare files from data.cms.gov. An NPI identifies who bills; it is not a license.

Figures on PlainDoctor are read from the federal files each page names (CMS NPPES, Medicare Part D, MIPS, Open Payments; the HHS-OIG exclusion list only as counts) and from Census population estimates, with the file date shown beside them. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of Aug 9, 2026.